Estonia Ends OTC Access To Codeine
Concerns over addiction to, and deliberate misuse of, codeine in Estonia has led the national regulator to reverse-switch the opioid from OTC to prescription-only status.
You may also be interested in...
Ireland’s drug regulator HPRA has initiated a formal regulatory procedure to determine if OTC remains the appropriate classification for codeine-containing products. The agency says the move is in response to a growing understanding of the potential impacts of addiction to codeine at low doses.
Prompted by reports of abuse leading to deaths, the European Medicines Agency's PRAC is recommending that combination drugs containing codeine and ibuprofen be reverse-switched across the EU to prescription-only status.
Promethazine has been reverse-switched from OTC to prescription status in France, with rising abuse of the drug in the so-called Purple Drank cocktail one of the motivating factors for the move by the country's health ministry.